HELIOS ACTION

HELIOS ACTION is dedicated to advancing research and fostering collaboration within the field of haemoglobinopathies. Focused on networking and capacity building, HELIOS ACTION participates in the European project CA22119, working to integrate, harmonise, and disseminate knowledge related to haemoglobinopathies, including Sickle Cell Disease and thalassaemia syndromes.

HELIOS ACTION strives to build a network of excellence, supporting advancements in understanding and treatment of these conditions. The company’s dedication to research services makes it a key player in driving progress and innovation in the field. HELIOS ACTION is committed to excellence and making a significant impact through its work.

We invite the management of HELIOS ACTION to create a customized and exclusive company showcase and product listing on our platform. This will allow you to further highlight your contributions and connect with a wider audience. We believe that this will greatly benefit your organization and the communities you serve.